This inventor holds 1 USPTO granted patent. Top assignee: Howard University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Robert L. Copeland
Introduction
Robert L. Copeland is a notable inventor based in Washington, DC. He has made significant strides in the field of medical treatments, particularly concerning Parkinson's disease. His innovative approach utilizes nicotine as a potential therapeutic agent, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Robert L. Copeland holds a patent for a method aimed at treating or mitigating Parkinson's disease symptoms or progression. This method involves administering an effective amount of nicotine to a subject in need, either through inhalation using a nicotine inhaler or via nasal spray. The patent highlights the expectation of significant dose-dependent improvement of all symptoms through these delivery methods. This novel treatment approach offers new hope for individuals suffering from Parkinson's disease.
Career Highlights
Copeland is affiliated with Howard University, where he continues to contribute to research and innovation in the medical field. His work reflects a dedication to improving patient outcomes and exploring new avenues for treatment.
Collaborations
One of his notable collaborators is Yousef Tizabi, with whom he has worked on advancing research related to his patent.
Conclusion
Robert L. Copeland's innovative work in developing a nicotine-based treatment for Parkinson's disease exemplifies the potential of medical inventions to transform lives. His contributions to the field are significant and reflect a deep commitment to addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile